| Literature DB >> 3314832 |
M J Ahern1, C Reid, T P Gordon, M McCredie, P M Brooks, M Jones.
Abstract
We have performed the first controlled study of colchicine in acute gout, to determine its efficacy and toxicity, and to define the natural history of acute gout. Two-thirds of colchicine-treated patients improved after 48 hours, but only one-third of the patients receiving placebo demonstrated similar improvement. The colchicine-treated patients responded earlier; significant differences from placebo were shown after 18-30 hours. All patients given colchicine developed diarrhea after a median time of 24 hours (mean dose of colchicine 6.7 mg). This side effect occurred before relief of pain in most patients.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3314832 DOI: 10.1111/j.1445-5994.1987.tb01232.x
Source DB: PubMed Journal: Aust N Z J Med ISSN: 0004-8291